DSpace - Tor Vergata >
Facoltà di Medicina e Chirurgia >
Tesi di dottorato in medicina >

Please use this identifier to cite or link to this item: http://hdl.handle.net/2108/780

Full metadata record

DC FieldValueLanguage
contributor.advisorPallone, Francesco-
contributor.authorFina, Daniele-
date.accessioned2009-02-03T17:22:55Z-
date.available2009-02-03T17:22:55Z-
date.issued2009-02-03T17:22:55Z-
identifier.urihttp://hdl.handle.net/2108/780-
description19. cicloen
description.abstractIn both Crohn’s disease (CD) and ulcerative colitis (UC), the major forms of inflammatory bowel diseases (IBD) in humans, the pathologic process consists of an aberrant local immune response to components of the bacterial microflora, due to abnormally strong effector cell activity that is poorly controlled by counter-regulatory mechanisms. There is also evidence that mucosal immune cells actively interact with non-immune cells to promote tissue damage, and that cytokines are essential mediators of this cross-talk. Interleukin-21 (IL-21), the latest member of the common gamma-chain-dependent cytokine family, is a product of activated CD4+ T cells and natural killer T cells. IL-21 is produced in excess in CD tissue, where it helps sustain the ongoing Th1 inflammation. High IL-21 production occurs also in the inflamed colon of most patients with UC, a disease that is not associated with a marked Th1 cell response. This suggests that, in the gut, IL-21 can modulate additional inflammatory pathways other than enhancing Th1 cell immunity. Indeed, IL-21 enhances the secretion of extracellular matrix degrading enzymes by fibroblasts, and of the T cell chemoattractant, MIP-3alpha, by epithelial cells. These data collectively indicate that IL-21 is a mediator of the chronic inflammatory response in CD and UC, and suggest that IL-21 may be an emerging therapeutic target in IBD.en
format.extent1524491 bytes-
format.mimetypeapplication/pdf-
language.isoenen
subjectIBDen
subjectcytokinesen
subjectIL-21en
subjectIL-21Ren
subjectcommon -chainen
subjectmatrix metalloproteinasesen
subjectMIP-3en
subject.classificationMED/12 Gastroenterologiaen
titleInterleukin-21 controls inflammatory pathways in IBDen
typeDoctoral thesisen
degree.nameDottorato in fisiopatologia sperimentaleen
degree.levelDottoratoen
degree.disciplineFacoltà di medicina e chirurgiaen
degree.grantorUniversità degli studi di Roma Tor Vergataen
date.dateofdefenseA.A. 2006/2007en
Appears in Collections:Tesi di dottorato in medicina

Files in This Item:

File Description SizeFormat
Tesi - Daniele Fina.pdf1488KbAdobe PDFView/Open

Show simple item record

All items in DSpace are protected by copyright, with all rights reserved.